D. Jane

发表

Distinct NMDA Receptor Subpopulations Contribute to Long-Term Potentiation and Long- Term Depression Induction

S. Hrabetova, P. Serrano, N. Blace, 2000, The Journal of Neuroscience.

Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors

G. Collingridge, D. Jane, Z. Bashir, 1993, Nature.

NMDA receptor-dependent long-term potentiation comprises a family of temporally overlapping forms of synaptic plasticity that are induced by different patterns of stimulation

Thomas M. Sanderson, G. Collingridge, M. Zhuo, 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

Assembly and Trafficking of Homomeric and Heteromeric Kainate Receptors with Impaired Ligand Binding Sites

D. Jane, E. Molnár, Caroline L Scholefield, 2018, Neurochemical Research.

Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists

M. Mayer, D. Jane, G. Alushin, 2011, Neuropharmacology.

Mapping the Ligand Binding Sites of Kainate Receptors: Molecular Determinants of Subunit-Selective Binding of the Antagonist [3H]UBP310

D. Jane, E. Molnár, Caroline L Scholefield, 2010, Molecular Pharmacology.

Anticonvulsant dicarboxyphenylglycines differentially modulate excitatory amino acid release in the rat cerebral cortex

D. Jane, M. Croucher, J. J. Lee, 2003, Brain Research.

that are induced by different patterns of stimulation family of temporally overlapping forms of synaptic plasticity NMDA receptor-dependent long-term potentiation comprises a

Thomas M. Sanderson, G. Collingridge, D. Jane, 2013 .

Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.

G. Collingridge, D. Jane, D. Monaghan, 2012, Journal of medicinal chemistry.

Different NMDA receptor subtypes mediate induction of long‐term potentiation and two forms of short‐term potentiation at CA1 synapses in rat hippocampus in vitro

G. Collingridge, D. Jane, D. Monaghan, 2013, The Journal of physiology.

Ca2+-calmodulin increases RyR2 open probability yet reduces ryanoid association with RyR2.

D. Jane, R. Sitsapesan, C. Sigalas, 2009, Biophysical journal.

Antagonist activity of α‐substituted 4‐carboxyphenylglycine analogues at group I metabotropic glutamate receptors expressed in CHO cells

D. Jane, G. Collingridge, A. Doherty, 1999, British journal of pharmacology.

Design and Nuclear Magnetic Resonance (NMR) Structure Determination of the Second Extracellular Immunoglobulin Tyrosine Kinase A (TrkAIg2) Domain Construct for Binding Site Elucidation in Drug Discovery

D. Jane, J. Hemmings, R. Sessions, 2014, Journal of medicinal chemistry.

The Startle Disease Mutation E103K Impairs Activation of Human Homomeric α1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site*

D. Jane, P. Biggin, L. Sivilotti, 2017, The Journal of Biological Chemistry.

Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists.

H. Tse, D. Jane, D. Monaghan, 2005, Journal of medicinal chemistry.

(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord

D. Jane, D. Schoepp, P. Howson, 2001, Neuropharmacology.

Putative Receptors Underpinning l-Lactate Signalling in Locus Coeruleus

D. Jane, A. Teschemacher, S. Kasparov, 2018, Neuroglia.

(2018). Putative Receptors Underpinning L-Lactate Signalling in Locus Coeruleus. Neuroglia , 1 (2), 365-380.

D. Jane, A. Teschemacher, S. Kasparov, 2018 .

Characterisation of an mGlu8 receptor-selective agonist and antagonist in the lateral and medial perforant path inputs to the dentate gyrus

G. Collingridge, D. Jane, Z. Bortolotto, 2013, Neuropharmacology.

Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.

G. Collingridge, D. Jane, D. Monaghan, 2019, European journal of medicinal chemistry.

Synthesis of Simple Oxetanes Carrying Reactive 2-Substituents

D. Jane, R. Millar, J. Hill, 1987 .

Synthesis of phenylglycine derivatives as potent and selective antagonists of group III metabotropic glutamate receptors.

D. Jane, B. Clark, S. Conway, 2001, Bioorganic & medicinal chemistry letters.

Kainate receptors: Pharmacology, function and therapeutic potential

G. Collingridge, D. Jane, D. Lodge, 2009, Neuropharmacology.

Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices

G. Collingridge, D. Jane, Z. Bortolotto, 2021, Neuropharmacology.

N-Methyl-d-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse

D. Jane, D. Monaghan, N. Lozovaya, 2009, Journal of Pharmacology and Experimental Therapeutics.

The glutamate story

D. Jane, J. Watkins, Jeffrey C Watkins, 2006, British journal of pharmacology.

The 1980s: d-AP5, LTP and a Decade of NMDA Receptor Discoveries

D. Jane, Z. Bortolotto, J. Watkins, 2018, Neurochemical Research.

Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity

G. Collingridge, D. Jane, Z. Bortolotto, 2018, Neuropharmacology.

ACET is a highly potent and specific kainate receptor antagonist: Characterisation and effects on hippocampal mossy fibre function

G. Collingridge, M. Mayer, D. Jane, 2009, Neuropharmacology.

Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain.

D. Jane, H. Sondermann, R. Oswald, 2009, Biochemistry.

Mechanism of partial agonism at the GluR2 AMPA receptor: Measurements of lobe orientation in solution.

D. Jane, R. Oswald, M. K. Fenwick, 2008, Biochemistry.

NR2B‐ and NR2D‐containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones

D. Jane, A. Gibb, J. Barber, 2008, The Journal of physiology.

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

D. Jane, D. Schoepp, Darryle D. Schoepp, 1999, Neuropharmacology.

Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.

D. Jane, D. Bleakman, R. Kamboj, 1997, Journal of medicinal chemistry.

Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators

D. Jane, D. Monaghan, Z. Bortolotto, 2021, Neuropharmacology.

The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus

G. R. Seabrook, G. Collingridge, D. Jane, 1997, Neuropharmacology.

Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices

G. Collingridge, H. Tse, D. Jane, 1996, British journal of pharmacology.

Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system

T. Salt, D. Jane, J. Watkins, 1993, Neuroscience.

Long-term potentiation and the role of N-methyl-d-aspartate receptors

G. Collingridge, D. Jane, Z. Bortolotto, 2015, Brain Research.

Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones

G. Collingridge, D. Jane, C. Davies, 1995, British journal of pharmacology.

Glutamate release inhibiting properties of the novel mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence

D. Jane, F. Gasparini, M. Croucher, 2001, Neuropharmacology.

Metabotropic glutamate autoreceptors of the mGlu5 subtype positively modulate neuronal glutamate release in the rat forebrain in vitro

D. Jane, M. Croucher, L. Thomas, 2000, Neuropharmacology.

Agonists of cyclic AMP-coupled metabotropic glutamate receptors in adult rat cortical slices.

H. Tse, D. Jane, P. Roberts, 1996, European journal of pharmacology.

Induction of Different Forms of LTP Different Calcium Sources Are Narrowly Tuned to the

Thomas M. Sanderson, K. Harris, G. Collingridge, 2015 .

Glutamate receptors ionotropic

D. Jane, D. Monaghan, Bihua Feng, 2005 .

Synthesis and pharmacological characterisation of arctigenin analogues as antagonists of AMPA and kainate receptors.

G. Collingridge, D. Jane, E. Molnár, 2021, Organic & biomolecular chemistry.

Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors

G. Collingridge, D. Jane, D. Monaghan, 2020, Nature Communications.

Crystal Structures of the Kainate Receptor GluR5 Ligand Binding Core Dimer with Novel GluR5-Selective Antagonists

M. Mayer, D. Jane, Mark L Mayer, 2006, The Journal of Neuroscience.

Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.

G. Collingridge, D. Jane, Z. Bortolotto, 2005, Journal of medicinal chemistry.

Pharmacology of NMDA Receptors

D. Jane, D. Monaghan, 2009 .

Structure-activity relationship studies on N3-substituted willardiine derivatives acting as AMPA or kainate receptor antagonists.

G. Collingridge, D. Jane, D. Bleakman, 2006, Journal of medicinal chemistry.

Antagonism of recombinant and native GluK3-containing kainate receptors

D. Jane, D. Perrais, C. Mulle, 2009, Neuropharmacology.

Inhibition of Kainate Receptors Reduces the Frequency of Hippocampal Theta Oscillations

Robert U Muller, G. Collingridge, R. Muller, 2007, The Journal of Neuroscience.

Anti-epileptogenic and anticonvulsant activity of l-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist

D. Jane, M. Croucher, H. Bradford, 1997, Brain Research.

Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord

H. Tse, D. Jane, J. Watkins, 1996, Neuropharmacology.

The Different Effects on Recognition Memory of Perirhinal Kainate and NMDA Glutamate Receptor Antagonism: Implications for Underlying Plasticity Mechanisms

J. Aggleton, D. Jane, Z. Bashir, 2006, The Journal of Neuroscience.

Multiple roles of GluN2B-containing NMDA receptors in synaptic plasticity in juvenile hippocampus

G. Collingridge, D. Jane, D. Monaghan, 2017, Neuropharmacology.

Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.

D. Jane, D. Monaghan, E. Burnell, 2018, Journal of medicinal chemistry.

Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists

D. Jane, Julia C. A. More, Nigel P. Dolman, 2003, British journal of pharmacology.

The novel antagonist 3‐CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C‐fibres

D. Jane, Julia C. A. More, Helen M Troop, 2002, British journal of pharmacology.

N-Methyl-D-aspartate ( NMDA ) Receptor NR 2 Subunit Selectivity of a Series of Novel Piperazine-2 , 3-dicarboxylate Derivatives : Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA 3-CA 1 Synapse

D. Jane, D. Monaghan, N. Lozovaya, 2009 .

Identification of Subunit- and Antagonist-Specific Amino Acid Residues in the N-Methyl-d-aspartate Receptor Glutamate-Binding Pocket

D. Skifter, D. Jane, D. Monaghan, 2005, Journal of Pharmacology and Experimental Therapeutics.

The effect of competitive antagonist chain length on NMDA receptor subunit selectivity

D. Jane, D. Monaghan, Bihua Feng, 2005, Neuropharmacology.

Identification of subunit-specific and antagonist-specific amino acid residues in the NMDA receptor glutamate binding pocket

D. Skifter, D. Jane, D. Monaghan, 2005 .

Structure–activity analysis of a novel NR2C/NR2D‐preferring NMDA receptor antagonist: 1‐(phenanthrene‐2‐carbonyl) piperazine‐2,3‐dicarboxylic acid

H. Tse, D. Skifter, D. Jane, 2004, British journal of pharmacology.

Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.

D. Jane, D. Monaghan, J. Christie, 2000, The Journal of pharmacology and experimental therapeutics.

Glutamate receptor ion channels : Activators and inhibitors

H. Tse, D. Skifter, D. Jane, 2000 .

Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist

G. Collingridge, D. Jane, Z. Bortolotto, 2004, Neuropharmacology.

Small conductance calcium-activated potassium channels: From structure to function

D. Jane, N. Marrion, S. Goodchild, 2010, Progress in Neurobiology.

AMPA Glutamate Receptor

D. Jane, 2008 .

Kainate Glutamate Receptor

D. Jane, 2008 .

Pharmacological differentiation of kainate receptors on neonatal rat spinal motoneurones and dorsal roots

D. Jane, P. Roberts, N. K. Thomas, 1998, Neuropharmacology.

Dicarboxyphenylglycines antagonize AMPA- but not kainate-induced depolarizations in neonatal rat motoneurones.

D. Jane, P. Clayton, N. K. Thomas, 1997, European journal of pharmacology.

The NMDA receptor as a target for cognitive enhancement

David Lodge, Graham L. Collingridge, G. Collingridge, 2013, Neuropharmacology.

Lack of inhibition of human plasma cholinesterase and red cell acetylcholinesterase by antimony compounds including stibine

D. Jane, P. Taberner, S. Hussain, 1998, Human & experimental toxicology.

Extrasynaptic NR2D-Containing NMDARs Are Recruited to the Synapse during LTP of NMDAR-EPSCs

R. Anwyl, D. Jane, S. Harney, 2008, The Journal of Neuroscience.

α-methyl derivatives of serine-O-phosphate as novel, selective competitive metabotropic glutamate receptor antagonists

H. Tse, D. Jane, J. Watkins, 1996, Neuropharmacology.

Novel potent selective phenylglycine antagonists of metabotropic glutamate receptors.

D. Jane, P. Roberts, N. Toms, 1996, European journal of pharmacology.

Analysis of Derivatives Subtypes Agonist and Antagonist Activities of Phenylglycine for Different Cloned Metabotropic Glutamate Receptor

D. Jane, S. Nakanishi, J. Watkins, 1994 .

Allosteric Block of KCa2 Channels by Apamin*

D. Jane, N. Marrion, Cédric Lamy, 2010, The Journal of Biological Chemistry.

GLUK1 receptor antagonists and hippocampal mossy fiber function.

G. Collingridge, D. Jane, Z. Bortolotto, 2009, International review of neurobiology.

Kainate receptors and mossy fiber LTP.

G. Collingridge, D. Jane, Z. Bortolotto, 2005, Neurotoxicology.

Binding of the new radioligand (S)-[3 H]AMPA to rat brain synaptic membranes: Effects of a series of structural analogues of the non-NMDA receptor agonist willardiine

D. Jane, D. Sunter, P. Roberts, 1995, Neuropharmacology.

Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice

D. Jane, B. Meldrum, P. Beart, 2001, Neuropharmacology.

Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine (DCG-IV)

D. Jane, M. Croucher, H. Bradford, 1998, Brain Research.

Synthesis of a Series of Novel 3,9-Disubstituted Phenanthrenes as Analogues of Known N-Methyl-d-aspartate Receptor Allosteric Modulators

G. Collingridge, D. Jane, D. Monaghan, 2015, Synthesis.

Pharmacological characterization of a novel negative allosteric modulator of NMDA receptors, UBP792

Dinesh Y. Gawande, D. Jane, D. Monaghan, 2021, Neuropharmacology.

Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives

G. Collingridge, D. Jane, D. Monaghan, 2017, Neuropharmacology.

(RS)-2-Chloro-5-Hydroxyphenylglycine (CHPG) Activates mGlu5, but not mGlu1, Receptors Expressed in CHO Cells and Potentiates NMDA Responses in the Hippocampus

G. Collingridge, D. Jane, J. Henley, 1997, Neuropharmacology.

Neuronal calcium sensors and synaptic plasticity.

G. Collingridge, D. Jane, Kwangwook Cho, 2009, Biochemical Society transactions.

Dynamin-dependent Membrane Drift Recruits AMPA Receptors to Dendritic Spines*

D. Jane, J. Henley, F. Jaskolski, 2009, Journal of Biological Chemistry.

The NMDA receptor intracellular C‐terminal domains reciprocally interact with allosteric modulators

R. Malinow, D. Jane, D. Monaghan, 2019, Biochemical pharmacology.

Dynamics of the S1S2 Glutamate Binding Domain of GluR2 Measured Using 19F NMR Spectroscopy*

D. Jane, R. Oswald, A. Loh, 2007, Journal of Biological Chemistry.

Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones

D. Jane, A. Gibb, F. Suárez, 2010, The European journal of neuroscience.

The Role of GLUK5-Containing Kainate Receptors in Entorhinal Cortex Gamma Frequency Oscillations

D. Jane, M. Cunningham, Heather L. Stanger, 2008, Neural plasticity.

Pre‐ and post‐synaptic functions of kainate receptors at glutamate and GABA synapses in the rat entorhinal cortex

D. Jane, S. Chamberlain, Roland S. G. Jones, 2012, Hippocampus.

Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptors

G. Collingridge, D. Jane, J. Sherwood, 2013, Neuropharmacology.

(S)‐homoquisqualate: a potent agonist at the glutamate metabotropic receptor

D. Jane, J. Watkins, P. Roberts, 1992, British journal of pharmacology.

An interchangeable role for kainate and metabotropic glutamate receptors in the induction of rat hippocampal mossy fiber long-term potentiation in vivo

G. Collingridge, D. Jane, Z. Bortolotto, 2015, Hippocampus.

Differences in kainate receptor involvement in hippocampal mossy fibre long-term potentiation depending on slice orientation

G. Collingridge, D. Jane, J. Sherwood, 2012, Neurochemistry International.

Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonists.

G. Collingridge, M. Mayer, D. Jane, 2007, Journal of medicinal chemistry.

Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-d-aspartate receptors

G. Collingridge, D. Jane, D. Monaghan, 2012, Neurochemistry International.

Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators

D. Jane, D. Monaghan, B. Costa, 2012, Neurochemistry International.

Agonists and competitive antagonists: structure-activity and molecular modelling studies

D. Jane, J. Watkins, H. J. Olverman, 1995 .

Metabotropic glutamate receptor mGlu2 is resistant to homologous agonist-induced desensitization but undergoes protein kinase C-mediated heterologous desensitization.

D. Jane, P. Roberts, P. Howson, 2010, European journal of pharmacology.

Antagonism of the synaptic depressant actions of l-AP4 in the lateral perforant path by MAP4

H. Tse, D. Jane, J. Garthwaite, 1995, Neuropharmacology.

A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors

D. Skifter, D. Jane, D. Monaghan, 2010, Journal of Pharmacology and Experimental Therapeutics.

NMDA Glutamate Receptor

D. Jane, 2008 .

Two Phenylglycine Derivatives Antagonize Responses to l-AP4 in ON Bipolar Cells of the Amphibian Retina

H. Tse, D. Jane, R. Miller, 1997, Neuropharmacology.

Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist

D. Jane, J. Watkins, M. Croucher, 1995, Brain Research.

Biological and Biophysical Aspects of Ligand-Gated Ion Channel Receptor Superfamilies

D. Jane, D. Monaghan, J. Boyle, 2006 .

Synthesis of Simple Oxetanes Carrying Reactive 2-Substituents

D. Jane, R. Millar, J. Hill, 1988 .

Different NMDAR subtypes mediate induction of LTP and two forms of STP at CA 1 synapses in the rat hippocampus in vitro

G. Collingridge, D. Jane, D. Monaghan, 2012 .

Actions of LY341495 on metabotropic glutamate receptor‐mediated responses in the neonatal rat spinal cord

D. Jane, P. Howson, 2003, British journal of pharmacology.

Metabotropic glutamate receptor antagonists, like GABAB antagonists, potentiate dorsal root-evoked excitatory synaptic transmission at neonatal rat spinal motoneurons in vitro

H. Tse, D. Jane, P. Headley, 1997, Neuroscience.

Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo

D. Jane, D. Monaghan, C. Ali, 2011, Molecular Neurodegeneration.

Phenylglycine derivatives as antagonists of group III metabotropic glutamate receptors expressed on neonatal rat primary afferent terminals

D. Jane, S. Conway, P. Howson, 2003, British journal of pharmacology.

Antagonism of presynaptically mediated depressant responses and cyclic AMP-coupled metabotropic glutamate receptors.

D. Jane, J. Watkins, D. Sunter, 1994, European journal of pharmacology.

Metabotropic glutamate receptors contribute to the induction of long-term depression in the CA1 region of the hippocampus.

G. Collingridge, D. Jane, Z. Bashir, 1993, European journal of pharmacology.

Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors

G. Collingridge, D. Jane, D. Monaghan, 2020, Nature Communications.

Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid

D. Jane, D. Monaghan, B. Laube, 2012, Neuropharmacology.

[3H]Homoquinolinate Binds to a Subpopulation of NMDA Receptors and to a Novel Binding Site

H. Tse, D. Skifter, D. Jane, 1998, Journal of neurochemistry.

Compounds for use in modulating the nmda receptor

D. Jane, D. Monaghan, B. Costa, 2011 .

Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity

G. Collingridge, D. Jane, Z. Bortolotto, 2018, Neuropharmacology.

Antagonism of mGlu Receptors and Potentiation of EPSCs at Rat Spinal Motoneurones In Vitro

H. Tse, D. Jane, P. Headley, 1997, Neuropharmacology.

Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats.

D. Jane, B. Meldrum, P. Yip, 1997, European journal of pharmacology.

Activation of cyclic AMP-dependent protein kinase inhibits the desensitization and internalization of metabotropic glutamate receptors 1a and 1b.

S. Mundell, D. Jane, P. Roberts, 2004, Molecular pharmacology.

An interchangeable role for kainate and metabotropic glutamate receptors in the induction of rat hippocampal mossy fiber long-term potentiation in vivo

G. Collingridge, D. Jane, Z. Bortolotto, 2015, Hippocampus.

Neuronal calcium sensors and synaptic plasticity.

G. Collingridge, D. Jane, Kwangwook Cho, 2009, Biochemical Society transactions.

Small conductance calcium-activated potassium channels: From structure to function

D. Jane, N. Marrion, S. Goodchild, 2010, Progress in Neurobiology.

Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators

D. Jane, D. Monaghan, B. Costa, 2012, Neurochemistry International.

Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.

D. Jane, D. Monaghan, E. Burnell, 2018, Journal of Medicinal Chemistry.